Building the Hematopoietic Stem Cell Niche

建立造血干细胞生态位

基本信息

  • 批准号:
    8137505
  • 负责人:
  • 金额:
    $ 76.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-15 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A hierarchal and tightly controlled organization of various cell types is the hallmark of normal tissues and organs, and the hypothesis underlying this proposal is that pre-defining the specific location and resultant cell- cell interactions of individual cells within a 3D tissue construct will allow one to create highly functional tissues in which the role of cell-cell interactions on cell phenotype can be precisely delineated. This concept will be explored by developing a 3D model of human hematopoiesis, in which osteoprogenitors and vascular cells will be probed for their roles in defining the hematopoietic stem cell (HSC) niche. The specific aims include (1) the development of microfluidic techniques to allow large-scale encapsulation of single cells in highly defined extracellular matrix mimics in order to determine how matrix cues regulate mesenchymal stem cell differentiation at the single cell level, (2) the creation of hybrid integrated circuit/microfluidic circuit systems to enable one to assemble picoliter drops containing individual cells and synthetic ECM into 3D assemblies with pre-defined structure and organization, and (3) determining whether appropriate in vitro assembly of HSCs and cells representative of the bone marrow HSC niche can yield functional hematopoietic tissues capable of recreating hematopoiesis in vitro. Success in this project will lead to the creation of a new set of tools that will enable formation of 3D tissues with precisely defined cell placement, and homotypic and heterotypic cell-cell interactions. These tools are likely to be broadly useful to the creation of new in vitro models of tissue development and drug screening, and in vivo tissue replacements from a variety of cell types. As stem cells are particularly sensitive to environmental cues, inappropriate cell-cell and cell-matrix interactions likely lead to the irreversible and undesirable alterations in stem cell differentiation fate found in culture. The systems developed in this project will allow us to investigate the specific role of vascular cells and osteoprogenitors/osteoblasts in maintaining the human HSC niche, which is a difficult question to address in vivo. It is crucial to better define and create models of the niche to understand normal hematopoiesis and pathologies involving blood cells, and to enable hematopoiesis on demand in various therapeutic venues. The key studies to date on this topic have relied on rodent models, and the relevance of many findings to human biology is currently unclear. (End of Reviewers' Comment)
描述(由申请人提供): 各种细胞类型的分级和严格控制的组织是正常组织和器官的标志,并且该提议背后的假设是预先定义3D组织构建体内的单个细胞的特定位置和所得的细胞-细胞相互作用将允许创建高度功能性的组织,其中细胞-细胞相互作用对细胞表型的作用可以被精确描绘。这一概念将通过开发一个三维模型的人类造血,其中骨祖细胞和血管细胞将探讨其在定义造血干细胞(HSC)的利基的作用。具体目标包括(1)开发微流体技术以允许在高度限定的细胞外基质模拟物中大规模包封单细胞,以确定基质线索如何在单细胞水平调节间充质干细胞分化,(2)混合集成电路的产生/微流体回路系统,使人们能够将含有单个细胞和合成ECM的皮升液滴组装成具有预定义结构和组织的3D组件,和(3)确定HSC和代表骨髓HSC小生境的细胞的适当体外组装是否可以产生能够在体外重建造血的功能性造血组织。该项目的成功将导致创建一套新的工具,这些工具将能够形成具有精确定义的细胞放置以及同型和异型细胞-细胞相互作用的3D组织。这些工具可能广泛用于创建组织发育和药物筛选的新体外模型,以及从各种细胞类型的体内组织替代物。由于干细胞对环境因素特别敏感,不适当的细胞-细胞和细胞-基质相互作用可能导致培养物中发现的干细胞分化命运的不可逆和不期望的改变。在这个项目中开发的系统将使我们能够研究血管细胞和骨祖细胞/成骨细胞在维持人类HSC生态位中的特定作用,这是一个难以在体内解决的问题。关键是要更好地定义和创建利基模型,以了解正常的造血和涉及血细胞的病理,并使造血在各种治疗场所的需求。迄今为止,关于这一主题的关键研究都依赖于啮齿动物模型,许多发现与人类生物学的相关性目前尚不清楚。 (End评论员评论)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(6)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David J Mooney其他文献

Subcutaneous biodegradable scaffolds for restimulating the antitumour activity of pre-administered CAR-T cells.
皮下可生物降解支架,用于重新刺激预施用的 CAR-T 细胞的抗肿瘤活性。
  • DOI:
    10.1038/s41551-024-01216-4
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    28.1
  • 作者:
    David K. Y. Zhang;Joshua M. Brockman;Kwasi Adu;Yutong Liu;Yoav Binenbaum;Irene de Lázaro;Miguel C. Sobral;Rea Tresa;David J Mooney
  • 通讯作者:
    David J Mooney
Angioid streaks in beta thalassaemia minor.
轻微β地中海贫血出现血管样条纹。
805-4 Biodegradable scaffolds incorporating vascular endothelial growth factor as a novel sustained delivery platform to induce angiogenesis
  • DOI:
    10.1016/s0735-1097(04)92001-3
  • 发表时间:
    2004-03-03
  • 期刊:
  • 影响因子:
  • 作者:
    Qinghua Sun;Ruth Chen;David J Mooney;Sanjay Rajagopalan;P.Michael Grossman
  • 通讯作者:
    P.Michael Grossman

David J Mooney的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David J Mooney', 18)}}的其他基金

Viscoelasticity and T Cell Production
粘弹性和 T 细胞生产
  • 批准号:
    10566883
  • 财政年份:
    2022
  • 资助金额:
    $ 76.61万
  • 项目类别:
Engineering Skeletal Muscle WIth Biodegradable Hydrogels
用可生物降解水凝胶工程骨骼肌
  • 批准号:
    9894440
  • 财政年份:
    2019
  • 资助金额:
    $ 76.61万
  • 项目类别:
Scaffolds mimicking antigen presenting cells
模拟抗原呈递细胞的支架
  • 批准号:
    9789238
  • 财政年份:
    2018
  • 资助金额:
    $ 76.61万
  • 项目类别:
Scaffolds mimicking antigen presenting cells
模拟抗原呈递细胞的支架
  • 批准号:
    10001355
  • 财政年份:
    2018
  • 资助金额:
    $ 76.61万
  • 项目类别:
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ
原位产生患者特异性抗原的生物材料癌症疫苗
  • 批准号:
    10053676
  • 财政年份:
    2017
  • 资助金额:
    $ 76.61万
  • 项目类别:
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ
原位产生患者特异性抗原的生物材料癌症疫苗
  • 批准号:
    10305629
  • 财政年份:
    2017
  • 资助金额:
    $ 76.61万
  • 项目类别:
MSC Encapsulation with Thin Gel Coating
具有薄凝胶涂层的 MSC 封装
  • 批准号:
    9383973
  • 财政年份:
    2017
  • 资助金额:
    $ 76.61万
  • 项目类别:
Biomaterial based breast cancer vaccine
基于生物材料的乳腺癌疫苗
  • 批准号:
    8830976
  • 财政年份:
    2013
  • 资助金额:
    $ 76.61万
  • 项目类别:
Biomaterial based breast cancer vaccine
基于生物材料的乳腺癌疫苗
  • 批准号:
    9047279
  • 财政年份:
    2013
  • 资助金额:
    $ 76.61万
  • 项目类别:
Building the Hematopoietic Stem Cell Niche
建立造血干细胞生态位
  • 批准号:
    8704933
  • 财政年份:
    2011
  • 资助金额:
    $ 76.61万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 76.61万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 76.61万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.61万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.61万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 76.61万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.61万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 76.61万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 76.61万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 76.61万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.61万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了